Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Southern Copper Corp (SCCO) vs TransMedics Group Inc (TMDX) Price & Performance

Southern Copper CorpTrade
TransMedics Group IncTrade

Price performance (Past 24H)

Key statistics

Southern Copper Corp vs TransMedics Group Inc — how do they compare? Southern Copper Corp trades at $187.95 (market cap $146.07B), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: Southern Copper Corp is far larger — about 57.5× TransMedics Group Inc's market cap, and Southern Copper Corp pays a 2.28% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.

SCCOTMDX
Market Cap
$146.07B$2.54B
Sector
Basic MaterialsTechnology
52-Week High
$218.85$150.42
52-Week Low
$90.54$61.99
Enterprise Value
$148.12B$2.94B
Dividend Yield
2.28%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Southern Copper Corp

Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. Southern Copper generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. Its geographical segments are The Americas, Europe, and Asia.

Read more on SCCO

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.

Read more on TMDX